<?xml version="1.0" ?>
<document id="06c0371d82953f5c35ee8bff3e5165d5aa1516de">
  <chunk id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c0" text="National Key Basic Research Program of China (2007CB512401), the Major Program of National Natural Science Foundation of China (30930086) and the General Program of National Natural Science Foundation of China"/>
  <chunk id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1" text="The inhibitory receptor programmed death-1 (PD-1) has the capacity to maintain peripheral tolerance and limit immunopathological damage; however, its precise role in fulminant viral hepatitis (FH) has yet to be described. Here, we investigated the functional mechanisms of PD-1 as related to FH pathogenesis induced by the murine hepatitis virus strain-3 (MHV-3). High levels of PD-1-positive CD4 + , CD8 + T cells, NK cells and macrophages were observed in liver, spleen, lymph node and thymus tissues following MHV-3 infection. PD-1-deficient mice exhibited significantly higher expression of the effector molecule which initiates fibrinogen deposition, fibrinogen-like protein 2 (FGL2), than did their wild-type (WT) littermates. As a result, more severe tissue damage was produced and mortality rates were higher. Fluorescence doublestaining revealed that FGL2 and PD-1 were not co-expressed on the same cells, while quantitative RT-PCR demonstrated that higher levels of IFN-c and TNF-a mRNA transcription occurred in PD-1-deficient mice in response to MHV-3 infection. Conversely, in vivo blockade of IFN-c and TNF-a led to efficient inhibition of FGL2 expression, greatly attenuated the development of tissue lesions, and ultimately reduced mortality. Thus, the up-regulation of FGL2 in PD-1-deficient mice was determined to be mediated by IFN-c and TNF-a. Taken together, our results suggest that PD-1 signaling plays an essential role in decreasing the immunopathological damage induced by MHV-3 and that manipulation of this signal might be a useful strategy for FH immunotherapy.">
    <entity charOffset="79-89" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e0" ontology_id="HP_0030646" text="peripheral" type="phenotype"/>
    <entity charOffset="176-191" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e1" ontology_id="HP_0006562" text="viral hepatitis" type="phenotype"/>
    <entity charOffset="182-191" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e2" ontology_id="HP_0012115" text="hepatitis" type="phenotype"/>
    <entity charOffset="295-307" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e3" ontology_id="GO_0009405" text="pathogenesis" type="gene_function"/>
    <entity charOffset="330-339" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e4" ontology_id="HP_0012115" text="hepatitis" type="phenotype"/>
    <entity charOffset="751-757" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e5" ontology_id="HP_0012828" text="severe" type="phenotype"/>
    <entity charOffset="992-1010" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e6" ontology_id="GO_0009299" text="mRNA transcription" type="gene_function"/>
    <entity charOffset="1410-1419" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e7" ontology_id="GO_0023052" text="signaling" type="gene_function"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e0" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e3" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p0" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e0" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e6" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p1" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e0" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e7" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p2" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e1" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e3" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p3" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e1" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e6" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p4" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e1" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e7" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p5" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e2" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e3" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p6" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e2" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e6" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p7" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e2" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e7" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p8" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e3" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e4" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p9" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e3" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e5" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p10" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e4" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e6" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p11" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e4" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e7" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p12" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e5" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e6" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p13" relation="true"/>
    <pair e1="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e5" e2="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.e7" id="06c0371d82953f5c35ee8bff3e5165d5aa1516de.c1.p14" relation="true"/>
  </chunk>
</document>
